Table 1 Distribution of patients and visual impairment among various clinical categories of ocular TB
From: Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis
Anterior uveitis | Intermediate uveitis | Retinal vasculitis | Multifocal serpiginoid choroiditis | Panuveitis | Others | Total | ||
|---|---|---|---|---|---|---|---|---|
Total number of eyes | 5 | 3 | 31 | 6 | 15 | 1 | 61 | |
Mean presenting BCVA ± SD | 0.62 ± 0.95 | 0.73 ± 0.49 | 0.85 ±0.91 | 0.55 ± 0.65 | 0.97 ± 0.79 | 0.4 ± 0.0 | 0.82 ± 0.82 | |
Median (range) | 0.30 (0.0 to 2.30) | 0.50 (0.40 to 1.30) | 0.60 (0.0 to 3.0) | 0.3 (0 to 1.80) | 0.90 (0 to 2.30) | 0.4 (0.4to 0.4) | 0.50 (0.0 to 3.0) | |
Mean worst BCVA ± SD | 0.84 ± 1.21 | 1.46 ± 1.34 | 1.36 ± 0.91 | 1.02 ± 0.54 | 1.17 ± 0.69 | 2.5 ± 0.0 | 1.26 ± 0.87 | |
Median (range) | 0.30(0.20 to 3.0) | 0.90 (0.50 to 3.0) | 1.30 (0 to 3.0) | 0.75 (0.5 to 1.8) | 1.30 (0.0 to 2.30) | 2.5 (2.5 to 2.5) | 1.30 (0.0 to 3.0) | |
Mean final BCVA ± SD | 0.72 ± 1.28 | 1.2 ± 1.56 | 0.71 ± 0.88 | 0.1 ± 0.06 | 0.49 ± 0.63 | 0.1 ± 0.0 | 0.61 ± 0.85 | |
Median (range) | 0.20 (0.10 to 3.0) | 0.30 (0.30 to 3.0) | 0.30 (0.30 to 3.0) | 0.10 (0.0 to 0.20) | 0.20 (0.0 to 2.30) | 0.1 (0.1 to 0.1) | 0.20 (0 to 3.0) | |
Number of eyes with moderate visual loss (BCVA <6/18 and ≥6/60) | P | - | - | 5 | 1 | 3 | - | 9 |
W | - | 1 | 6 | 3 | 4 | - | 14 | |
F | - | - | 6 | - | 3 | - | 9 | |
Number of eyes with severe visual loss (BCVA <6/60 and ≥3/60) | P | - | 1 | 4 | - | 3 | - | 8 |
W | - | - | 8 | - | 4 | - | 12 | |
F | - | - | 4 | - | 1 | - | 5 | |
Number of eyes with BCVA <3/60 | P | 1 | - | 7 | 1 | 4 | - | 13 |
W | 1 | 1 | 11 | 2 | 4 | 1 | 20 | |
F | 1 | 1 | 4 | - | 1 | - | 7 | |
Mean duration of visual loss (weeks) ± SD | 5.91 ± 13.22 | 0.38 ± -0.66 | 36.31 ± 53.37 | 8.42 ± 8.81 | 21.27 ± 28.69 | 11.29 ± 0.0 | 25.2 ± 42.37 | |
Median (range) | 0.0 (0 to 29.57) | 0.0 (0.0 to 1.142) | 13.57 (0 to 206.42) | 5.92 (0 to 24.57) | 11.14 (0.0 to 86.571) | 11.29 (11.29 to 11.29) | 6.43 (0 to 206.42) | |
Mean duration of follow up (weeks) ± SD | 65.23 ± 37.13 | 123.71 ± 170.97 | 111.06 ± 88.78 | 59.071 ± 12.63 | 90.86 ± 73.68 | 141.42 ± 0.0 | 98.34 ± 81.81 | |
Median (range) | 41(36.71 to 105.86) | 25(25 to 321.14) | 63.71(12.42 to 301.71) | 63.71 (37 to 69.29) | 47.14(21 to 216.42) | 141.42 (0 to 141.42) | 63.71 (12.43 to 321.14) | |